At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy and Tolerability of Nanoparticle Albumin Bound Paclitaxel (Abraxane) in Patients 65 and Older With Locally Advanced or Metastatic Breast Cancer
In Brief
A Phase 2 clinical trial evaluating Laboratory Biomarker Analysis, Nab-paclitaxel, and 1 other intervention for Locally Advanced Breast Carcinoma and 7 related conditions. Active but no longer recruiting, targeting 40 participants across 4 sites.
Detailed Summary
This phase II trial studies the side effects of nab-paclitaxel in treating older patients with breast cancer that has spread from where it started to nearby tissue or lymph nodes (locally advanced) or to other places in the body (metastatic). Drugs used in chemotherapy, such as nab-paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.
Study Details
Timeline
Interventions
Correlative studies
Given IV
Ancillary studies